Location History:
- Seattle, WA (US) (2001)
- Rochester, MN (US) (2001 - 2012)
- New Haven, CT (US) (2013)
- Baltimore, MD (US) (2010 - 2015)
- Sparks Glencoe, MD (US) (2010 - 2015)
- Hampden, CT (US) (2019)
- Hamden, CT (US) (2012 - 2024)
Company Filing History:
32 out of 1,746 
11 out of 3,687 
3 out of 541 
Years Active: 2001-2024
Areas of Expertise:
Title: Exploring the Innovations of Inventor Lieping Chen
Introduction:
Lieping Chen, a notable inventor in the field of medical research and immunology, hails from Hamden, CT (US). With an impressive portfolio of 44 patents, his contributions have greatly impacted the diagnosis and treatment of cancer.
Latest Patents:
1. "Costimulatory B7-H1 in Renal Cell Carcinoma Patients": This patent revolves around assessing B7-H1 expression in cancerous tissues for diagnostic purposes. It also includes methods for treatment with agents that target B7-H1-receptor interactions, selecting suitable candidates for immunotherapy, and inhibiting B7-H1 expression.
2. "B7-H5, a Costimulatory Polypeptide": Here, Lieping Chen introduces B7-H5 costimulatory polypeptides, along with encoding nucleic acids. These innovations aim to enhance T cell responses and potentially revolutionize cancer treatment approaches.
Career Highlights:
Lieping Chen has made significant strides in the medical field through his work at prestigious institutions such as the Mayo Foundation for Medical Education and Research and The Johns Hopkins University. His research has led to groundbreaking discoveries in cancer immunotherapy.
Collaborations:
During his career, Lieping Chen has collaborated with esteemed professionals in the field, including Scott E Strome and Eugene D Kwon. Together, they have advanced the understanding of immunology and its applications in cancer treatment.
Conclusion:
In conclusion, Lieping Chen's groundbreaking inventions and patents have not only advanced the field of immunology but have also provided new avenues for the diagnosis and treatment of cancer. His innovative contributions continue to shape the landscape of medical research, offering hope to patients and healthcare professionals worldwide.